Dermira to Present at the 14th Annual Needham Healthcare Conference
08 avr. 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
25 mars 2015 16h09 HE
|
Dermira, Inc.
DRM01 Phase 2b Trial in Acne to Start April 2015
Conference Call Today at 4:30 p.m. Eastern Time
MENLO PARK, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty...
Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting
23 mars 2015 07h00 HE
|
Dermira, Inc.
MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Report Fourth Quarter and Full Year 2014 Financial Results
18 mars 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated dermatology products to...
Dermira Announces Late-Breaking Oral Presentation on DRM01 in Acne at 2015 AAD Annual Meeting
12 mars 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Announces Positive Phase 2b Results for DRM04 in Patients With Hyperhidrosis
05 févr. 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira to Present at the 2015 Leerink Global Healthcare Conference
29 janv. 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis
08 janv. 2015 02h00 HE
|
Dermira, Inc.
Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis
Program includes the first Phase 3 study in psoriasis comparing two...
Dermira Added to Russell 2000(R) Index
22 déc. 2014 08h00 HE
|
Dermira, Inc.
MENLO PARK, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...
Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update
12 nov. 2014 16h05 HE
|
Dermira, Inc.
REDWOOD CITY, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology...